Advertisement
Screener

VERACYTE, INC. (VCYT) Graph

VCYT Revenue Flow

Filed revenue amounts for 2026-04-01 to 2026-06-30. Coverage is partial. Unconnected amounts are separate disclosures; they must not be added together.

  • 2026-06-30: Revenue $150.32M; Cost of revenue (m); Research and development $29.44M; Operating expenses (m).
  • 2026-03-31: Revenue $139.07M; Cost of revenue (m); Research and development $27.10M; Operating expenses (m).
  • 2025-12-31: Revenue $140.64M*; Cost of revenue (m); Research and development $20.85M*; Operating expenses (m).
  • 2025-09-30: Revenue $131.87M; Cost of revenue (m); Research and development $15.98M; Operating expenses (m).

Product or service

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VCYT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Product$3.86MBiopharmaceutical And OtherBiopharmaceutical Revenue$802.00KBiopharmaceutical And OtherContract Manufacturing And Testing$0.00BiopharmaceuticalAnd Other$802.00KTesting$145.66MTesting Other$4.50MRevenue$150.32MGross profit$108.55MOperating income$22.98MOther income, net$3.54MResearch & development$29.44MPre-tax income$26.52MNet income$25.49M

Segment

Separate filed amounts; connecting flows are not established. Components and totals may overlap.

VCYT revenue flowFiled amounts. Only explicit calculation relationships connect amounts; dimensional membership alone does not establish an additive flow.Reportable Segment$150.32MRevenue$150.32MGross profit$108.55MOperating income$22.98MOther income, net$3.54MResearch & development$29.44MPre-tax income$26.52MNet income$25.49M

Finer product or service dollar figures and nonoverlapping groupings are shown only where supported by the retained filing evidence. Growth percentages are never converted to revenue dollars.

Historical revenue and expense breakdown

Revenue and expense 3 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$150.32M(m)$29.44M(m)$1.03M$25.49M
2026-03-31$139.07M(m)$27.10M(m)$1.27M$28.71M
2025-12-31$140.64M*(m)$20.85M*(m)-$515.00K*$41.20M*
2025-09-30$131.87M(m)$15.98M(m)-$248.00K$19.14M
2025-06-30$130.16M(m)$16.26M(m)$2.23M-$980.00K
2025-03-31$114.47M(m)$17.72M(m)$381.00K$7.05M
2024-09-30$115.86M(m)$17.57M(m)$1.69M$15.15M
2024-06-30$114.43M(m)$16.46M(m)$1.63M$5.73M
2024-03-31$96.84M(m)$15.96M(m)-$44.00K-$1.86M
2023-09-30$90.11M(m)$13.32M(m)-$154.00K-$29.62M
2023-06-30$90.32M(m)$12.54M(m)$125.00K-$8.40M
2023-03-31$82.42M(m)$12.77M(m)$0.00-$8.09M
2022-09-30$75.59M(m)$10.77M(m)-$152.00K-$8.72M
2022-06-30$72.86M(m)$9.38M(m)-$115.00K-$9.53M
2022-03-31$67.78M(m)$9.17M(m)-$3.00K-$14.46M
2021-09-30$60.37M(m)$8.01M(m)-$1.35M-$14.13M
2021-06-30$55.10M(m)$6.25M(m)-$152.00K-$9.04M
2021-03-31$36.70M(m)$5.34M(m)-$3.79M-$41.87M
2020-12-31$34.54M(m)(m)(m)(m)-$8.04M
2020-09-30$31.12M(m)$4.04M(m)$0.00-$4.12M
2020-06-30$20.70M(m)$4.17M(m)$0.00-$11.03M
2020-03-31$31.12M(m)$4.41M(m)$0.00-$11.72M
2019-12-31$29.73M$9.67M*(m)(m)(m)-$7.46M
2019-09-30$30.97M$9.11M$3.64M(m)$0.00-$730.00K
2019-06-30$30.14M$8.78M$3.33M(m)$0.00-$2.49M
2019-03-31$29.53M$8.51M$3.44M(m)(m)-$1.92M
2018-12-31$25.75M(m)(m)(m)(m)(m)
2018-09-30$23.47M$8.26M$3.42M(m)(m)(m)
2018-06-30$22.75M$8.25M$4.60M(m)(m)(m)
2018-03-31$20.04M$7.87M$3.67M(m)(m)(m)
2017-12-31$19.60M(m)(m)(m)(m)(m)
2017-09-30$17.52M$7.17M$3.05M(m)(m)(m)
2017-06-30$18.41M$6.96M$3.60M(m)(m)(m)
2017-03-31$16.43M$6.30M$4.03M(m)(m)(m)
2016-12-31$18.26M(m)(m)(m)(m)(m)
2016-09-30$18.60M$6.37M$4.01M(m)(m)(m)
2016-06-30$14.68M$6.30M$4.27M(m)(m)(m)
2016-03-31$13.55M$6.28M$3.46M(m)(m)(m)
2015-12-31$14.04M(m)(m)(m)(m)(m)
2015-09-30$12.34M$5.62M$3.56M$21.22M(m)(m)
2015-06-30$11.91M$5.14M$3.10M$20.98M(m)(m)
2015-03-31$11.22M$4.57M$2.79M$18.77M(m)(m)
2014-12-31$12.20M(m)(m)(m)(m)(m)
2014-09-30$9.84M$4.17M$2.23M$17.65M(m)(m)
2014-06-30$8.68M$3.97M$2.24M$15.24M(m)(m)
2014-03-31$7.48M$3.61M$2.13M$14.05M(m)(m)
2013-12-31$6.84M(m)(m)(m)(m)-$5.89M
2013-09-30$5.59M$3.13M$2.03M$11.70M(m)-$6.30M
2013-06-30$5.07M$3.23M$1.90M$10.48M(m)-$6.49M
2013-03-31$4.38M$2.77M$2.01M$10.28M(m)-$6.89M
2012-12-31$4.46M(m)(m)(m)(m)-$4.84M
2012-09-30$3.22M$1.98M$1.73M$8.16M(m)-$4.94M
2012-06-30$2.48M(m)(m)(m)(m)-$4.63M
2012-03-31$1.47M(m)(m)(m)(m)-$4.25M

Revenue and expense 6 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2026-06-30$289.39M(m)$56.54M(m)$2.30M$54.20M
2025-06-30$244.64M(m)$33.98M(m)$2.61M$6.07M
2024-06-30$211.27M(m)$32.43M(m)$1.58M$3.87M
2023-06-30$172.74M(m)$25.31M(m)$125.00K-$16.49M
2022-06-30$140.65M(m)$18.54M(m)-$118.00K-$23.99M
2021-06-30$91.81M(m)$11.59M(m)-$3.95M-$50.91M
2020-06-30$51.83M(m)$8.58M(m)$0.00-$22.74M
2019-06-30$59.66M$17.29M$6.76M(m)$0.00-$4.41M
2018-06-30$42.79M$16.11M$8.28M(m)(m)(m)
2017-06-30$34.84M$13.26M$7.63M(m)(m)(m)
2016-06-30$28.23M$12.58M$7.73M(m)(m)(m)
2015-06-30$23.13M$9.71M$5.89M$39.75M(m)(m)
2014-06-30$16.15M$7.57M$4.37M$29.29M(m)(m)
2013-06-30$9.45M$6.00M$3.91M$20.76M(m)(m)

Revenue and expense 9 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-09-30$376.51M(m)$49.97M(m)$2.36M$25.20M
2024-09-30$327.13M(m)$50.00M(m)$3.28M$19.02M
2023-09-30$262.85M(m)$38.63M(m)-$29.00K-$46.11M
2022-09-30$216.24M(m)$29.32M(m)-$270.00K-$32.72M
2021-09-30$152.18M(m)$19.59M(m)-$5.30M-$65.03M
2020-09-30$82.95M(m)$12.62M(m)$0.00-$26.86M
2019-09-30$90.64M$26.40M$10.41M(m)$0.00-$5.14M
2018-09-30$66.26M$24.37M$11.70M(m)(m)(m)
2017-09-30$52.36M$20.43M$10.68M(m)(m)(m)
2016-09-30$46.83M$18.95M$11.73M(m)(m)(m)
2015-09-30$35.46M$15.32M$9.45M$60.98M(m)(m)
2014-09-30$25.99M$11.74M$6.60M$46.94M(m)(m)
2013-09-30$15.05M$9.14M$5.94M$32.46M(m)(m)
2012-09-30$7.17M$4.98M$4.89M$20.98M(m)(m)

Revenue and expense 12 month

Period endRevenueCost of revenueResearch and developmentOperating expensesIncome taxNet income
2025-12-31$517.14M(m)$70.81M(m)$1.85M$66.40M
2024-12-31$445.76M(m)$69.29M(m)$1.61M$24.10M
2023-12-31$361.05M(m)$57.30M(m)-$2.21M-$74.40M
2022-12-31$296.54M(m)$40.60M(m)$133.00K-$36.60M
2021-12-31$219.51M(m)$29.84M(m)-$6.09M-$75.60M
2020-12-31$117.48M(m)$17.20M(m)$0.00-$34.91M
2019-12-31$120.37M$36.08M$14.85M(m)$0.00-$12.60M
2018-12-31$92.01M$33.08M$14.82M$114.24M$0.00-$23.00M
2017-12-31$71.95M$28.20M$13.88M$98.49M$0.00(m)
2016-12-31$65.08M$25.46M$15.32M$93.89M$0.00(m)
2015-12-31$49.50M$21.50M$12.80M$82.97M$0.00(m)
2014-12-31$38.19M$16.61M$9.80M$67.20M$0.00(m)
2013-12-31$21.88M$12.61M$7.81M$45.06M$0.00(m)
2012-12-31$11.63M$7.58M$6.61M$30.56M(m)(m)
2011-12-31$2.65M$2.92M$6.68M$17.91M(m)(m)

Similar stocks

Stock NameCountryMarket CapPE Ratio
Celcuity Inc. (CELC)United States$3.887B-22.62
CareDx, Inc. (CDNA)United States$3.174B13.21
GRAIL, Inc. (GRAL)United States$5.591B-7.78
RadNet, Inc. (RDNT)United States$5.611B-229.65
Fortrea Holdings Inc. (FTRE)United States$1.903B-19.43
Personalis, Inc. (PSNL)United States$1.769B-13.30
CASTLE BIOSCIENCES INC (CSTL)United States$1.074B-37.45
Lumexa Imaging Holdings, Inc. (LMRI)United States$0.951B
Fulgent Genetics, Inc. (FLGT)United States$0.593B-6.70
BIODESIX INC (BDSX)United States$0.312B